JCU Corporation (TYO:4975)
Japan · Delayed Price · Currency is JPY 6,200.00
-230.00 (-3.58%)
Jul 24, 2026, 3:30 PM JST
JCU Corporation Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 29,672 | 29,672 | 28,356 | 24,859 | 27,137 | 24,256 |
Revenue Growth | 4.64% | 4.64% | 14.07% | -8.39% | 11.88% | 14.46% |
Gross Profit Gross Profit Growth | 20,610 | 20,610 | 18,601 | 15,184 | 16,434 | 15,729 |
Operating Income Operating Income Growth | 12,156 | 12,156 | 10,513 | 8,098 | 9,291 | 8,991 |
Net Income Net Income Growth | 9,074 | 9,074 | 7,497 | 5,530 | 6,013 | 6,370 |
Earnings Per Share EPS Growth | 365.71 | 365.71 | 297.68 | 216.94 | 232.59 | 243.80 |
EPS Growth | 22.86% | 22.86% | 37.22% | -6.73% | -4.60% | 36.73% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Pharmaceutical Business Pharmaceutical Business Growth | 26,926 | 26,926 | 24,155 | 21,681 | 24,529 | 22,949 |
Equipment Business Equipment Business Growth | 2,746 | 2,746 | 4,202 | 3,178 | 2,608 | 1,307 |
Total Total Growth | 29,672 | 29,672 | 28,357 | 24,860 | 27,138 | 24,256 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 24,229 | 24,229 | 26,112 | 27,037 | 24,180 | 19,519 |
Total Debt Total Debt Growth | 351 | 351 | 456 | 786 | 1,104 | 1,319 |
Net Cash (Debt) Net Cash Growth | 23,878 | 23,878 | 25,656 | 26,251 | 23,076 | 18,200 |
Net Cash Growth | -6.93% | -6.93% | -2.27% | 13.76% | 26.79% | 18.64% |
Net Cash Per Share Net Cash Per Share Growth | 962.36 | 962.36 | 1018.70 | 1029.81 | 892.62 | 696.57 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 9,038 | 9,038 | 8,426 | 6,029 | 7,840 | 5,091 |
Capital Expenditures CapEx Growth | -7,329 | -7,329 | -6,452 | -624 | -1,011 | -416 |
Free Cash Flow Free Cash Flow Growth | 1,709 | 1,709 | 1,974 | 5,405 | 6,829 | 4,675 |
Free Cash Flow Growth | -13.43% | -13.43% | -63.48% | -20.85% | 46.08% | -23.90% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 69.46% | 69.46% | 65.60% | 61.08% | 60.56% | 64.85% |
Operating Margin | 40.97% | 40.97% | 37.08% | 32.58% | 34.24% | 37.07% |
Pretax Margin | 42.36% | 42.36% | 38.65% | 32.27% | 35.04% | 37.95% |
Profit Margin | 30.58% | 30.58% | 26.44% | 22.25% | 22.16% | 26.26% |
FCF Margin | 5.76% | 5.76% | 6.96% | 21.74% | 25.16% | 19.27% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 180.000 | 95.000 | 76.000 | 70.000 | 66.000 | 57.000 |
Dividend Per Share Growth | 25.00% | 25.00% | 8.57% | 6.06% | 15.79% | 14.00% |
Dividend Yield | 2.90% | 1.79% | 2.40% | 1.85% | 2.04% | 1.49% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 16.95 | 14.44 | 10.56 | 18.10 | 14.50 | 16.92 |
Forward PE | 17.35 | 14.68 | 10.75 | 14.79 | 13.74 | 17.23 |
P/FCF Ratio | 89.32 | 76.67 | 40.09 | 18.51 | 12.77 | 23.05 |
PS Ratio | 5.14 | 4.42 | 2.79 | 4.03 | 3.21 | 4.44 |